Rituximab and lupus: good in real life, bad in controlled trials. Comment on the article by Lu et al
- PMID: 19714598
- DOI: 10.1002/art.24726
Rituximab and lupus: good in real life, bad in controlled trials. Comment on the article by Lu et al
Comment in
-
Global versus organ-specific outcome measures in systemic lupus erythematosus: comment on the articles by Furie et al, Nikpour et al, Wallace et al, Burgos et al, and Ramos-Casals et al.Arthritis Care Res (Hoboken). 2010 Apr;62(4):580-1; author replies 581-2. doi: 10.1002/acr.20053. Arthritis Care Res (Hoboken). 2010. PMID: 20391517 No abstract available.
Comment on
-
A retrospective seven-year analysis of the use of B cell depletion therapy in systemic lupus erythematosus at University College London Hospital: the first fifty patients.Arthritis Rheum. 2009 Apr 15;61(4):482-7. doi: 10.1002/art.24341. Arthritis Rheum. 2009. PMID: 19333973
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous